Preview

Erik Peterson at Biometra: Case Analysis

Satisfactory Essays
Open Document
Open Document
816 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Erik Peterson at Biometra: Case Analysis
ERIK PETERSON AT BIOMETRA-CASE ANALYSIS

EXECUTIVE SUMMARY:
Biometra is a small company based in the Boston suburb of Woburn which was recently acquired by Scientific Materials (SciMat), in order to deepen its portfolio in vascular medical devices. Biometra focused chiefly on catheters, or tubes used to drain or inject fluids or to allow access of surgical instruments for medical procedures. The catheter would be the first product ever launched by Biometra and so its success was critical for both the companies.
Erik Peterson was hired as the Product Manager in charge of sales and marketing of Biometra’s catheter, shortly after completing his MBA. Due to sudden resignation of the Vice President of peripheral and vascular devices as well as certain key Biometra managers, Peterson was promoted to be the Acting General Manager (GM). From the case we see that even though Erik Peterson tries hard to meet the product target launch date, there are several issues that he and the organization are experiencing.
CRITICAL PROBLEMS: 1) Revision of original sales and distribution launch target date from February 1 to April 1 and only 3 weeks to prepare for the launch. 2) Equivocation with KOLs regarding support from the company, increasing the likelihood that they would withdraw from working relationships with Biometra. 3) Strained dynamics between him and his team, as well as issues between team members. 4) Technical delays, in locating commercial manufacturing facilities of Biometra to Costa Rica, some of which have been resolved, while others which are still pending may affect the product deliverability. 5) Low involvement of management in the various launch issues of Biometra as well as indifference of Peterson’s boss Hardy to the urgency of decisions.
The following are the underlying causes of all the above problems: 1) Lack of Experience: Erik’s promotion to the position of General Manager was due to a sense of urgency and not on the basis of

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Stryker produces the following products to be considered for this project. We believe ABC Medical will benefit from the use of these products:…

    • 749 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Biopure Case Summary

    • 847 Words
    • 4 Pages

    Biopure's two products, Hemopure for human use, and Oxyglobin for animal veterinary use, both represented a new blood substitute based treatment for managing patients' oxygen requirements in a broad range of potential medical applications. The main issue that is plaguing Biopure is how the possible launch of Oxyglobin will affect the future launch and pricing strategies of Hemopure, which could provide a larger return for their investment.…

    • 847 Words
    • 4 Pages
    Good Essays
  • Good Essays

    assign2

    • 1612 Words
    • 5 Pages

    In the laparoscopic industry in the U.S., distribution of MIS devices had been controlled by large companies of group purchasing organizations (GPOs). This caused a high barrier of entry for small and startup companies. GENICON, as a young U.S. firm, was not only able to remain open but actually thrived by focusing on its international distribution strategy since the early stages of its launch (Kupetz et al., 2010, p. 1). It grew business in different nations, like Pacific Rim, Middle East, Europe and Latin America by 2009 (Kupetz et al., 2010, p. 1). Since the approximately 80 per cent of GENICON’s business was derived outside the United States, a critical factor in its success had been choosing the right international markets. In 2010, Gary Haberland, the president of this company, narrowed four countries (China, India, Brazil and Russia) to consider which one to enter his business.…

    • 1612 Words
    • 5 Pages
    Good Essays
  • Better Essays

    The establishment of implantable pacemakers began in 1958. Notable doctors such as Ake Senning, Rune Elmqvist and W.M. Chardack along with Wilson Greatbatch, an engineer, were all instrumental in refining pacemaking devices and making them portable with the use of batteries (Sandro A.P. Haddad, 2006). Although these pacemakers were a vast improvement on previous models, they also had a fundamental flaw. The first implantable pacemakers were asynchronous and had the potential to compete with the natural rhythm of the heart. According to the Association of Surgical Technologists, these pacemakers are now rarely used because of the potential to cause ventricular fibrillation (Association of Surgical…

    • 763 Words
    • 4 Pages
    Better Essays
  • Powerful Essays

    product, we'll go out of business. Pretty soon, no one will be making heart pacemakers, and many people need them.…

    • 994 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    The founder of the CanGo Company had given little thought to the long range plans and direction of the company beyond the basic steps required to get the business in place. The organization’s successes could be attributed to the unique niche the CEO was able to fill for consumers mixed with old fashioned luck. Yes However, relying on these attributes to carry the business indefinitely would be ill advised. The largest risk in not utilizing strategic planning is failing to anticipate for fundamental changes in customer expectations, employee morale, regulatory requirements, competitive pressures, and economic changes. The company may lose valuable lead time and momentum when trying to catch up to these changes that could be severely detrimental to the company (Olsen). The first order of business for CanGo to move the company to the next stages and build a sustainable business would be to generate a vision statement, mission statement, and a specific strategic plan that can be used as roadmaps for the company’s next two to five years of operation. These elements should be considered the most important and immediate objectives for the top management of the company. They will form the basis of all other business…

    • 1575 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    Management Action Plan

    • 1164 Words
    • 5 Pages

    | * Lack of communication amongst team, particularly with major objectives * Quality of work (lack of experience in suitable reporting techniques, etc) * Unable to…

    • 1164 Words
    • 5 Pages
    Powerful Essays
  • Satisfactory Essays

    Belbins Roles

    • 351 Words
    • 2 Pages

    2) I feel the team had a lot of “plants” at some stages who struggled to come up with the initial spark of an idea with which to push forward. This created some issues within the team until the correct balance was formed. With too many plants in the team, bad ideas concealed good ones and too much time/resources was wasted in certain areas.…

    • 351 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Prepared to solve the zoning problems (failed to get the approval of the top management)…

    • 346 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    My whole childhood has climaxed to this crucial point of my life- my first footsteps into the world of medical science. I soared past elementary, middle, and high school in the hopes of becoming a professional in the healthcare industry, and what were once dreams is now becoming a reality. My general education classes at UCSD have trickled down to more specialized courses particular to my major, human biology. I have always appreciated the vastness of the human body and the many ways it can manipulate treatments to increase its performance and efficiency. Applied Medical is an advanced technological medical company that uses the skills of people with a wide range of backgrounds, such as engineering, clinical research, multimedia design, finance, and more, to create progressive minimally invasive and general surgical instruments. Applied…

    • 637 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Cost Of Health Care

    • 1590 Words
    • 7 Pages

    Innovations such as magnetic resonance imaging (MRI), new highly effective drugs, improvements in surgical procedures such as organ transplantation, coronary artery bypass surgery, just to name a few, have completely transform our modern way of life and the standards of health care. The research and development of medical technology have given us enormous outcomes and benefits. It is a source of hope for the prevention, effective treatment, and cure of diseases. Unfortunately, just like any new product, the cost of developing these new technologies and treatments is extremely high. Plus, unlike other technology, medical technology generally does not decrease in price over time (Fuchs & Garber:…

    • 1590 Words
    • 7 Pages
    Better Essays
  • Good Essays

    Dr. Romach Case

    • 1072 Words
    • 5 Pages

    John Cannon graduated from a prestigious West coast university where he majored in international business and had been a very successful biotechnology market analyst early in his career. He then joined and became a manger for (IML) International Medical Laboratories, a large biomedical equipment company managing the German subsidiary. IML specializes in expensive, high quality heart and lung machines that are used during open heart surgery. John’s job title was that of a manager and he was to be in charge of marketing their line internationally, he targeted Europe.…

    • 1072 Words
    • 5 Pages
    Good Essays
  • Good Essays

    In order to identify possible issues that are interfering with Meditech’s ability to remain a leader in the endoscopic market, to understand clearly an analysis will be conducted to identify meditech’s problems in the introduction of new products, concerns in manufacturing, and all its products. The analysis will also observe how problems occur both systemically and organizationally, and the reason why the customer service manager pays quick attention to such problems. Furthermore, suggestions will be made in order to improve Meditech’s position and remain relative in the medical industry.…

    • 773 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Technology has a growing presence in the world of medicine. As it advances, so do the medicine and treatment of patients suffering from health issues, such as cardiovascular disease. Over the years, the development and improvement of technology used by medical personnel around the world has helped save the lives of several people. The status of technology today in the medical field has greatly improved the prevention, diagnoses, and treatment of patients with cardiovascular diseases. Ultimately, it has changed the face of medicine, giving people a better chance at living longer and healthier lives.…

    • 2035 Words
    • 9 Pages
    Better Essays
  • Good Essays

    Biomax Case Summary

    • 1049 Words
    • 5 Pages

    Clive Meanwell is a bit of a scavenger. He established an organization four years back focused around the thought that there was cash to be made from medications that different organizations set aside. The first assignment for Meanwell and his partners was choosing what medications to save. The strategy was risky as there were half chances that this medicine will work or not so it was total gamble from Meanwell point of view. In the year of 1997, they had settled on Angiomax, an against blood-coagulating medication that Biogen had been creating as a more viable option to heparin, the opposition to thickening medication most broadly utilized as a part of the intense treatment of coronary heart disease. Upon looking into Biogen's clinical test outcomes, on the other hand, Meanwell had believed that a business still existed for the medication. In this way, in March 1997, the Medicines Company procured all rights to Angiomax and set out to finish the clinical trials that Biogen had started upon securing Angiomax in 1997, the Medicines Company set out to address a few issues. First and foremost, the organization led an affirming clinical study utilizing high risk angioplasty patients, second, in 1999 the Medicines Company contracted out creation of Angiomax to UCB Bioproducts, with the comprehension that UCB would endeavor to create a second-era assembling techinque to cut down the expense of generation. The Medicines Company raised almost 10 millions dollars to improve the…

    • 1049 Words
    • 5 Pages
    Good Essays